Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. The company is developing a unique and proprietary Click-to-Release platform to enable selective release of anticancer drugs in the tumor microenvironment. This platform has a broad set of application areas (antidrug conjugates, radioligands, T cell engagers and cytokines), and has the potential to increase antitumor efficacy while lowering potential toxicity for patients.
Tagworks Pharmaceuticals raised a €60 million Series A financing co-led by Gilde Healthcare to further develop its differentiated click chemistry platform and bring drug candidates to the clinic.
More Tagworks news
Nyxoah
Belgian Healthtech company focused on the treatment of sleep apnea.
![](https://gildehealthcare.com/wp-content/uploads/2021/05/NYXNOAH.png)
Levicept
UK-based Therapeutics company developing a novel therapy to treat chronic pain.
![](https://gildehealthcare.com/wp-content/uploads/2021/05/Levicept-1.png)
Eargo
US-based MedTech company selling hearing aid solutions to patients suffering from hearing loss.
![](https://gildehealthcare.com/wp-content/uploads/2021/07/Eargo-final-1.png)